oxybutynin has been researched along with glucagon-like peptide 1 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, G; Gu, Z; Yu, J | 1 |
1 review(s) available for oxybutynin and glucagon-like peptide 1
| Article | Year |
|---|---|
Glucose-Responsive Microneedle Patches for Diabetes Treatment.
Topics: Animals; Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glucagon-Like Peptide 1; Glucose; Humans; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hypoglycemic Agents; Insulin Infusion Systems; Insulin-Secreting Cells; Kinetics; Needles; Transdermal Patch; Translational Research, Biomedical | 2019 |